NGM Biopharmaceuticals(NGM) - 2023 Q4 - Annual Results

Exhibit 99.1 NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results South San Francisco, CA, March 11, 2024 – NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today provided recent business highlights and reported financial results for the fourth quarter and full year ended December 31, 2023. "In 2023, we made significant progress in patient enroll ...